Detection of a new JAK2 D620E mutation in addition to V617F in a patient with polycythemia vera

被引:32
作者
Gruenebach, F. [1 ]
Bross-Bach, U. [1 ]
Kanz, L. [1 ]
Brossart, P. [1 ]
机构
[1] Univ Tubingen, Dept Oncol Hematol Immunol Rheumatol & Pulm, Tubingen, Germany
关键词
D O I
10.1038/sj.leu.2404419
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2210 / 2211
页数:3
相关论文
共 8 条
  • [1] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
    Baxter, EJ
    Scott, LM
    Campbell, PJ
    East, C
    Fourouclas, N
    Swanton, S
    Vassiliou, GS
    Bench, AJ
    Boyd, EM
    Curtin, N
    Scott, MA
    Erber, WN
    Green, AR
    [J]. LANCET, 2005, 365 (9464) : 1054 - 1061
  • [2] ISHII T, 2006, BLOOD
  • [3] A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
    James, C
    Ugo, V
    Le Couédic, JP
    Staerk, J
    Delhommeau, F
    Lacout, C
    Garçon, L
    Raslova, H
    Berger, R
    Bennaceur-Griscelli, A
    Villeval, JL
    Constantinescu, SN
    Casadevall, N
    Vainchenker, W
    [J]. NATURE, 2005, 434 (7037) : 1144 - 1148
  • [4] Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
    Jones, AV
    Kreil, S
    Zoi, K
    Waghorn, K
    Curtis, C
    Zhang, LY
    Score, J
    Seear, R
    Chase, AJ
    Grand, FH
    White, H
    Zoi, C
    Loukopoulos, D
    Terpos, E
    Vervessou, EC
    Schultheis, B
    Emig, M
    Ernst, T
    Lengfelder, E
    Hehlmann, R
    Hochhaus, A
    Oscier, D
    Silver, RT
    Reiter, A
    Cross, NCP
    [J]. BLOOD, 2005, 106 (06) : 2162 - 2168
  • [5] Molecular pathogenesis of Philadelphia chromosome negative myeloprolife rative disorders
    Kralovics, R
    Skoda, RC
    [J]. BLOOD REVIEWS, 2005, 19 (01) : 1 - 13
  • [6] Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders
    McClure, R
    Mai, M
    Lasho, T
    [J]. LEUKEMIA, 2006, 20 (01) : 168 - 171
  • [7] Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain
    Saharinen, P
    Vihinen, M
    Silvennoinen, O
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2003, 14 (04) : 1448 - 1459
  • [8] SCHNITTGER S, 2006, LEUKEMIA